Bunkerhill MAC

by Bunkerhill Health  · Based in United States → — The Long-Horizon AI Agent for Health Systems
Cardiology Radiology

Regulatory Status Disclosed

Overview

Bunkerhill MAC is the first artificial intelligence algorithm to detect and quantify mitral annular calcification (MAC) on routine, non-gated chest CT scans. It is a key component of Bunkerhill Health’s broader Carebricks platform, which provides generative AI for clinical reasoning and action across health systems. The algorithm addresses a clinically important but often overlooked finding, bringing consistency and scale to the identification of MAC, which is linked to increased cardiovascular risk. By automatically identifying and quantifying MAC, Bunkerhill MAC helps clinicians capture crucial information consistently and at scale, aiding in guiding decision-making and research across cardiology and structural heart care. The Carebricks platform, where Bunkerhill MAC is available, enables health systems to design and deploy AI-powered, end-to-end workflows that integrate seamlessly with EHRs to improve care and efficiency without adding workload for clinicians.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered detection and quantification of Mitral Annular Calcification (MAC)
  • Analyzes routine, non-gated chest CT scans
  • Identifies patients at increased cardiovascular risk
  • Integrates with the Carebricks generative AI platform for clinical reasoning and action
  • Supports automated workflows for follow-up and care coordination
  • Developed and validated through a multi-institutional research consortium
  • Seamless integration with existing EHRs and clinical systems

Use Cases

  • Opportunistic screening for mitral annular calcification and associated cardiovascular risk
  • Early identification of patients who may benefit from further cardiovascular evaluation or treatment
  • Streamlining clinical workflows for cardiovascular risk assessment
  • Guiding decision-making and research in cardiology and structural heart care
  • Automating patient follow-up and care coordination for at-risk individuals
  • Improving patient outcomes and operational efficiency in healthcare systems

What Physicians Need to Know

ECG/EKG Analysis Capability
Bunkerhill Health offers ECG-EF, an FDA-clecleared AI algorithm that detects reduced left ventricular ejection fraction (LVEF), a key indicator of heart failure, using data from routine 12-lead electrocardiograms (ECGs). This allows for earlier identification of high-risk patients.
Cardiac CT/MRI Analysis
Bunkerhill Health has FDA-cleared AI algorithms for detecting and quantifying coronary artery calcium (CAC) and aortic valve calcium (AVC) on both non-contrast and contrast-enhanced chest CT scans. Additionally, Bunkerhill MAC is the first FDA-cleared AI algorithm to detect and quantify mitral annular calcification (MAC) on routine, non-gated chest CT scans.
Heart Failure Risk Prediction
The ECG-EF algorithm helps flag high-risk patients for heart failure earlier by detecting reduced LVEF from routine ECGs.
Coronary Artery Assessment
Bunkerhill Health's AI algorithms can identify and quantify coronary artery calcium (CAC) on chest CT scans, enabling early detection and risk stratification for coronary artery disease. This includes algorithms for both non-contrast and contrast-enhanced CTs.
Cardiac Monitoring Integration
Bunkerhill's ECG-EF model is available through HeartSciences' MyoVista Insights platform, which is a cloud-native ECG management system designed to integrate third-party, FDA-cleared AI results into clinical practice.
Real-Time Alert Capability
The Carebricks platform, which houses Bunkerhill's algorithms, can automate next steps such as notifying care teams and routing referrals. When a patient with elevated CAC is identified, their primary care provider or cardiologist is promptly notified.
Physician Tip

Bunkerhill Health's AI tools, such as ECG-EF and Bunkerhill MAC, leverage routine diagnostic data (ECGs and CT scans) to identify crucial cardiac indicators like reduced LVEF, coronary artery calcium, aortic valve calcium, and mitral annular calcification. These tools can help flag at-risk patients earlier, facilitating timely intervention and improved patient outcomes. The integration with platforms like Carebricks allows for automated workflows, notifications, and streamlined referrals, potentially reducing clinician workload and closing care gaps. Physicians can utilize these tools for proactive screening, risk stratification, and guiding decision-making in cardiology and structural heart care.

Bunkerhill Health's flagship platform, Carebricks, is designed to integrate with Electronic Health Records (EHRs) and other third-party platforms. It is FHIR-compliant, SOC 2 certified, and HIPAA compliant, ensuring secure and real-time access to patient data. Carebricks supports HL7v2 order and results workflows, single sign-on (SSO), and SMART on FHIR for EHR integration. The platform can automate various actions, including notifying care teams, routing referrals, streamlining prior authorization, automating registry submissions, and triggering actions in third-party platforms.

Details

Category Cardiology AI, Clinical Decision Support & Reference
Pricing Unknown
DeploymentCloud-based, integrates with EHRs.
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
SOC 2 Yes AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Radiology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2025-10-03K250662 510(k)Bunkerhill MAC

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Bunkerhill MAC

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Bunkerhill MAC.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

Bunkerhill MAC is the first FDA-cleared artificial intelligence algorithm designed to detect and quantify mitral annular calcification (MAC) on routine, non-gated chest CT scans. It helps cardiologists by automatically identifying and quantifying MAC, a condition often overlooked but linked to increased cardiovascular risk, thereby providing a new tool to understand risk and tailor patient care.
Bunkerhill MAC is available within Carebricks, Bunkerhill Health's AI platform for clinical reasoning and action. This platform allows health systems to apply AI-powered reasoning and FDA-cleared algorithms across patient data, customizing workflows to automate appropriate next steps seamlessly into existing clinical practices.
Bunkerhill MAC has received U.S. Food and Drug Administration (FDA) clearance. It is specifically cleared as a software device intended for use in detecting the presence and estimating the quantity of mitral annular calcification.
Yes, Bunkerhill Health offers other FDA-cleared algorithms for cardiovascular risk identification, such as detecting coronary artery calcium and aortic valve calcium on routine CT scans. Other companies also provide AI solutions in cardiology, including those for detecting various cardiovascular findings in medical images, improving angiography image quality, and automated image assessment.
While Bunkerhill MAC provides a valuable tool for detecting and quantifying MAC, it's important to remember that MAC itself is often discovered incidentally and its significance may be underrecognized. The algorithm runs on routine, non-gated chest CT scans, and while it helps standardize detection, clinical interpretation and patient management still rely on physician expertise.
By automatically identifying and quantifying MAC on routine chest CT scans, Bunkerhill MAC helps clinicians better understand cardiovascular risk and tailor patient care. This can lead to earlier detection of a condition linked to increased cardiovascular risk, including higher rates of mortality and complications in structural heart procedures.

Related Tools

Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA
Cardiology AI
Siemens Healthineers offers the ACUSON Sequoia, ACUSON Sequoia Select, and ACUSON Origin ultrasound systems, providing advanced imaging for various medical needs. The Sequoia line focuses on high-resolution imaging with deep penetration and reduced variability, while the AI-powered ACUSON Origin specializes in comprehensive cardiovascular diagnostics and interventions.
R30 Diagnostic Ultrasound System
Samsung Medison Co.
Cardiology AI
The Samsung Medison R30 Diagnostic Ultrasound System is a general-purpose, mobile, software-controlled diagnostic ultrasound system that offers a wide range of imaging capabilities and analysis tools for various clinical applications.

See all Cardiology AI tools →

More from Bunkerhill Health

Bunkerhill Abdominal Aortic Quantification (AAQ)
Bunkerhill Health
Cardiology AI
Bunkerhill AVC
Bunkerhill Health
Cardiology AI
Bunkerhill Health provides a generative AI platform, Carebricks, for clinical reasoning and action, integrating with EHRs to automate workflows and improve patient outcomes.
BunkerHill BMD
Bunkerhill Health
Endocrinology & Metabolic AI
Bunkerhill Contrast AVC
BunkerHill Health
Clinical Decision Support & Reference
Bunkerhill Health offers an AI-powered platform, Carebricks, that provides agentic AI infrastructure for hospitals and health systems, automating clinical reasoning and workflows.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-03 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.